Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,948
Active & Responsive
Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
for
Heart Failure, Heart Failure - NYHA II - IV
Location: Dallas TX, Minneota MN, Charleston SC
Sponsor: Echosens
Sex: All
Age: 18+
Code: NCT07222813
Recruiting
Active & ResponsiveNew
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
for
Head & Neck Squamous Cell Carcinoma, Non-Small Cell Lung Cancer,
Location: Irving TX, Orlando FL, Fairfax VA
Sponsor: Sutro Biopharma, Inc.
Sex: All
Age: 18+
Code: NCT07807345
Phase 1, Recruiting
Active & Responsive
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: Irving TX, Fort Worth TX, Houston TX, Omaha NE,
Location: Irving TX, Fort Worth TX, Fairfax VA, Orange CA,
Sponsor: Orion Corporation, Orion Pharma
Sex: All
Age: 18+
Code: NCT07563738
Phase 1, Phase 2, Recruiting
Active & Responsive
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: Dallas TX, San Antonio TX, St Louis MO, Omaha NE,
Sponsor: Tasca Therapeutics
Sex: All
Age: 18+
Code: NCT07030257
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
for
Solid Tumor, Non-Small-Cell Lung Cancer,
Location: Irving TX, Jefferson LA, St Louis MO, Atlanta GA,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT07094204
Phase 1, Recruiting
Active & Responsive
A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.
for
Metastatic Solid Tumors
Location: Irving TX, Houston TX, San Antonio TX, Nashville TN,
Sponsor: Erasca, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07021898
Phase 1, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
for
Breast Neoplasms
Location: Dallas TX, Fort Worth TX, Tyler TX, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06312176
Phase 3, Recruiting
Active & Responsive
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Dallas TX, Houston TX, St Louis MO, Nashville TN,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05216432
Phase 1, Recruiting
Active & Responsive
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
for
Liver Transplant
Location: Dallas TX, Omaha NE, Nashville TN, Chicago IL,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18+
Code: NCT06075745
Phase 2, Recruiting
Active & Responsive
NARCOMS Registry: A Multiple Sclerosis Registry
for
Multiple Sclerosis
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center